Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MDalgorithms is a dermatologist-founded, AI-native health-tech company specializing in personalized, technology-driven skin and hair care. Founded in 2016, the company leverages proprietary machine learning and computer vision models trained on a massive global dataset of dermatological images to provide real-time, remote analysis of skin and scalp conditions. Based on these AI assessments, MDalgorithms delivers fully customized, medical-grade treatment kits directly to consumers under its flagship brands: MDacne (for acne treatment), MDhair (for hair regrowth), and Nuvane (for longevity and anti-aging skincare). These kits combine FDA-approved over-the-counter active ingredients with dermatologist-formulated botanicals, adaptogens, and proprietary peptides. The company's direct-to-consumer platform is supported by ongoing remote teledermatology care, allowing users to track their progress and receive unlimited chat support from dermatologists and nurses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MDalgorithms.